Yoshida H, Onda M, Tajiri T, Umehara M, Mamada Y, Taniai N, Kaneko M, Mizuguchi Y, Uchida E, Yamashita K, Uchida E
First Department of Surgery, Nippon Medical School, Tokyo, Japan.
Hepatogastroenterology. 2000 Jul-Aug;47(34):1120-1.
A 69-year-old man with unresectable hepatocellular carcinoma and portal vein tumor thrombus was treated by chemotherapy with 5-fluorouracil. A dose of 500 mg/day of 5-fluorouracil was continuously administered via a central venous catheter. After 4 months, the alpha-fetoprotein level was decreased from 50,000 ng/mL to 4,760 ng/mL. Computed tomography revealed disappearance of the low-density area in the liver parenchyma, but the portal vein tumor thrombus was not changed. After 6 months, pancytopenia appeared and continuous infusion of 5-fluorouracil was stopped. After 8 months, the patient died of pneumonia, at which time the alpha-fetoprotein level was 12,000 ng/mL. Continuous intravenous infusion of 5-Fluorouracil was effective against unresectable primary hepatocellular carcinoma, but had little influence on portal vein tumor thrombus.
一名69岁患有无法切除的肝细胞癌和门静脉肿瘤血栓的男性接受了5-氟尿嘧啶化疗。通过中心静脉导管持续给予5-氟尿嘧啶,剂量为500毫克/天。4个月后,甲胎蛋白水平从50,000纳克/毫升降至4,760纳克/毫升。计算机断层扫描显示肝实质内低密度区域消失,但门静脉肿瘤血栓未改变。6个月后,出现全血细胞减少,停止了5-氟尿嘧啶的持续输注。8个月后,患者死于肺炎,此时甲胎蛋白水平为12,000纳克/毫升。持续静脉输注5-氟尿嘧啶对无法切除的原发性肝细胞癌有效,但对门静脉肿瘤血栓影响不大。